Cargando…
Western Moyamoya Phenotype: A Scoping Review
Moyamoya, a rare angiographic finding, is characterized by chronic and progressive stenosis at the terminal end of the internal carotid artery, followed by collateralization of the cerebral vasculature at the base of the skull. Coined by Suzuki and Takaku in 1969, the term “moyamoya” means a “puff o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693830/ https://www.ncbi.nlm.nih.gov/pubmed/34956795 http://dx.doi.org/10.7759/cureus.19812 |
_version_ | 1784619221966127104 |
---|---|
author | Miller, Raphael Unda, Santiago R Holland, Ryan Altschul, David J |
author_facet | Miller, Raphael Unda, Santiago R Holland, Ryan Altschul, David J |
author_sort | Miller, Raphael |
collection | PubMed |
description | Moyamoya, a rare angiographic finding, is characterized by chronic and progressive stenosis at the terminal end of the internal carotid artery, followed by collateralization of the cerebral vasculature at the base of the skull. Coined by Suzuki and Takaku in 1969, the term “moyamoya” means a “puff of smoke” in Japanese, a reference to the angiographic appearance of moyamoya collateralization. Moyamoya is most commonly found in East Asian countries, where much governmental and civilian effort has been expended to characterize this unique disease process. However, despite its rarity, the occurrence of moyamoya in Western countries is associated with significant divergence regarding incidence, gender, sex, age at diagnosis, clinical presentation, and outcomes. Here, we attempted to review the Western literature on moyamoya presentation using the PubMed database to characterize the Western phenotype of moyamoya. We were guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR). We reviewed papers generated from a search with keywords “moyamoya case report,” those reported from a Western institution, and those reported on a relevant association. Our scoping review demonstrated various clinical associations with moyamoya. Moreover, we summarized the demographic profile and clinical symptomatology, as well as reported disease associations to better elucidate the Western phenotype of moyamoya. |
format | Online Article Text |
id | pubmed-8693830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-86938302021-12-23 Western Moyamoya Phenotype: A Scoping Review Miller, Raphael Unda, Santiago R Holland, Ryan Altschul, David J Cureus Neurology Moyamoya, a rare angiographic finding, is characterized by chronic and progressive stenosis at the terminal end of the internal carotid artery, followed by collateralization of the cerebral vasculature at the base of the skull. Coined by Suzuki and Takaku in 1969, the term “moyamoya” means a “puff of smoke” in Japanese, a reference to the angiographic appearance of moyamoya collateralization. Moyamoya is most commonly found in East Asian countries, where much governmental and civilian effort has been expended to characterize this unique disease process. However, despite its rarity, the occurrence of moyamoya in Western countries is associated with significant divergence regarding incidence, gender, sex, age at diagnosis, clinical presentation, and outcomes. Here, we attempted to review the Western literature on moyamoya presentation using the PubMed database to characterize the Western phenotype of moyamoya. We were guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR). We reviewed papers generated from a search with keywords “moyamoya case report,” those reported from a Western institution, and those reported on a relevant association. Our scoping review demonstrated various clinical associations with moyamoya. Moreover, we summarized the demographic profile and clinical symptomatology, as well as reported disease associations to better elucidate the Western phenotype of moyamoya. Cureus 2021-11-22 /pmc/articles/PMC8693830/ /pubmed/34956795 http://dx.doi.org/10.7759/cureus.19812 Text en Copyright © 2021, Miller et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Miller, Raphael Unda, Santiago R Holland, Ryan Altschul, David J Western Moyamoya Phenotype: A Scoping Review |
title | Western Moyamoya Phenotype: A Scoping Review |
title_full | Western Moyamoya Phenotype: A Scoping Review |
title_fullStr | Western Moyamoya Phenotype: A Scoping Review |
title_full_unstemmed | Western Moyamoya Phenotype: A Scoping Review |
title_short | Western Moyamoya Phenotype: A Scoping Review |
title_sort | western moyamoya phenotype: a scoping review |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693830/ https://www.ncbi.nlm.nih.gov/pubmed/34956795 http://dx.doi.org/10.7759/cureus.19812 |
work_keys_str_mv | AT millerraphael westernmoyamoyaphenotypeascopingreview AT undasantiagor westernmoyamoyaphenotypeascopingreview AT hollandryan westernmoyamoyaphenotypeascopingreview AT altschuldavidj westernmoyamoyaphenotypeascopingreview |